NCT Number: NCT01828580
Safety and Performance Evaluation of the AutoLap System
The main objectives of this study are to evaluate the safety and performance of the AutoLap system in Laparoscopic Cholecystectomy procedures.
Looking for future studies?
Notify MeKey information
Age range
18 year–75 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Assuta Medical Center, Tel Aviv, Israel
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Signed and dated Informed Consent Form.
- Patients between 18 and 75 years of age inclusive who were scheduled for elective laparoscopic Cholecystectomy procedure.
Exclusion criteria
- Previous upper abdominal surgery and contraindications to Pneumoperitoneum.
- Pregnancy.
- Obesity (BMI >35 Kg/m2).
- Generalized peritonitis.
- Septic shock from cholangitis.
- Severe acute pancreatitis.
- Uncorrected coagulopathy.
- Previous abdominal operations which prevent safe abdominal access or progression of the procedure.
- Advanced cirrhosis with failure of hepatic function.
- Suspected gallbladder cancer.
- Acute cholecystitis
- Presence of any medical or psychiatric condition or any other condition that, in the opinion of the Investigator, could affect the successful participation of the patient in the study.
- Patient participates in any other clinical study 60 days prior to the start of the study and throughout the study duration.
Treatment and study plan
Primary outcomes
-
Adverse events
Time frame: participants will be followed for the duration of hospital stay, an expected average of 1-2 days
No conversion to open surgery from laparoscopic surgery due to using the AutoLap system 2) No AutoLap system related operative complications, that require further clinical intervention
-
Performance evaluation
Time frame: during surgery -defined as the time from the first abdominal incision until the surgical procedure is completed (skin incisions are closed).
The ability of the AutoLap system to successfully move the laparoscope to the surgeon's desired position
Secondary outcomes
-
system set-up time
Time frame: during surgery - defined as the time from the first abdominal incision until the surgical procedure is completed (skin incisions are closed).
defined as the time required from connecting the AutoLap's ARM to the bed rail
-
Average total procedure time
Time frame: during surgery - defined as the time from the first abdominal incision until the surgical procedure is completed (skin incisions are closed).
defined as the time from first abdominal incision until the surgical procedure is completed
-
Number of times that the laparoscope was removed for cleaning
Time frame: During surgery - defined as the time from the first abdominal incision until the surgical procedure is completed (skin incisions are closed).
-
Usability evaluation
Time frame: During surgery (at the end of the procedure)
the AutoLap system usability in laparoscopic procedures will be assessed by a questionnaire. The questionnaire assesses the surgeon's satisfaction with the use of the AutoLap in regard to easiness of use, convenient of movement control and its ability to be used in the OR without interfering with the surgical flow
Sponsors and collaborators
Lead sponsor
M.S.T. Medical Surgery Technology LTD.
Industry
Registry information
Official study title
Safety and Performance Evaluation of the AutoLap System - a Feasibility Study
Important dates
- Study start
- 2012
- Primary completion
- 2014
- Study completion
- 2014
- First posted
- Apr 10, 2013
- Registry last updated
- Dec 31, 2014
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.